An update on novel quantitative techniques in the context of evolving whole-body PET imaging

PET Clinics

Volumn 10, Issue 1, 2015, Pages 45-58

  Houshmand, Sina ^a   Salavati, Ali ^a   Hess, Søren ^b   Werner, Thomas J ^a   Alavi, Abass ^a   Zaidi, Habib ^c,d,e  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Glucose metabolism; Kinetic modeling; Quantification; Segmentation

Indexed keywords

TRACER; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; DUAL TIME POINT IMAGING; GLUCOSE METABOLISM; HUMAN; IMAGING; KINETICS; METABOLIC RATE; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE STUDY; TREATMENT PLANNING; TREATMENT RESPONSE; WHOLE BODY IMAGING; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; IMAGE ENHANCEMENT; PROCEDURES; SCINTISCANNING; THREE DIMENSIONAL IMAGING;

FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84913529703     PISSN: 15568598     EISSN: 18799809     Source Type: Journal    
DOI: 10.1016/j.cpet.2014.09.004     Document Type: Review

References (91)

1. S. Basu, H. Zaidi, and M. Houseni Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states Semin Nucl Med 37 2007 223 239
2. R. Boellaard Optimisation and harmonisation: two sides of the same coin? Eur J Nucl Med Mol Imaging 40 2013 982 984
3. S. Basu, T.C. Kwee, and D. Torigian Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET Eur J Nucl Med Mol Imaging 38 2011 1381 1382
4. H. Zaidi, and A. Alavi Trends in PET quantification: opportunities and challenges Clin Transl Imaging 2 2014 183 185
5. R. Boellaard, M.J. O'Doherty, and W.A. Weber FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 Eur J Nucl Med Mol Imaging 37 2010 181 200
6. 18F-FDG PET/CT 1.0 J Nucl Med 47 2006 885 895
7. A.J. Reader, and H. Zaidi Advances in PET image reconstruction PET Clin 2 2007 173 190
8. K.R. Zasadny, and R.L. Wahl Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction Radiology 189 1993 847 850
9. C.K. Kim, N.C. Gupta, and B. Chandramouli Standardized uptake values of FDG: body surface area correction is preferable to body weight correction J Nucl Med 35 1994 164 167
10. N. Sadato, T. Tsuchida, and S. Nakaumra Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours Eur J Nucl Med 25 1998 559 564
11. F. Kotasidis, C. Tsoumpas, and A. Rahmim Advanced kinetic modelling strategies: towards adoption in clinical PET imaging Clin Transl Imaging 2 2014 219 237
12. G. Wang, and J. Qi Direct estimation of kinetic parametric images for dynamic PET Theranostics 3 2013 802 815
13. 18F-FDG PET/CT" J Nucl Med 55 2014 350 351
14. A. Rahmim, J. Tang, and H. Zaidi Four-dimensional (4D) image reconstruction strategies in dynamic PET: beyond conventional independent frame reconstruction Med Phys 36 2009 3654 3670
15. N.A. Karakatsanis, M.A. Lodge, and A.K. Tahari Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application Phys Med Biol 58 2013 7391 7418
16. J. Huang, and F. O'Sullivan An analysis of whole body tracer kinetics in dynamic PET studies with application to image-based blood input function extraction IEEE Trans Med Imaging 33 2014 1093 1108
17. 18F-fluoro-deoxyglucose Semin Nucl Med 11 1981 24 31
18. M.E. Phelps, S.C. Huang, and E.J. Hoffman Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method Ann Neurol 6 1979 371 388
19. 11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects J Cereb Blood Flow Metab 2 1982 307 319
20. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man Circ Res 44 1979 127 137
21. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J Neurochem 28 1977 897 916
22. J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers Nucl Med Biol 27 2000 661 670
23. Y. Zhou, W. Ye, and J.R. Brasic Multi-graphical analysis of dynamic PET Neuroimage 49 2010 2947 2957
24. K.C. Schmidt, G. Lucignani, and L. Sokoloff Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination J Nucl Med 37 1996 394 399
25. G.J. Hunter, L.M. Hamberg, and N.M. Alpert Simplified measurement of deoxyglucose utilization rate J Nucl Med 37 1996 950 955
26. H. Zaidi Quantitative analysis in nuclear medicine imaging 2006 Springer New York
27. 11C]tyrosine PET J Nucl Med 38 1997 692 696
28. 18F]fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin J Comput Assist Tomogr 17 1993 115 123
29. J.W. Keyes Jr. SUV: standard uptake or silly useless value? J Nucl Med 36 1995 1836 1839
30. R. Boellaard Standards for PET image acquisition and quantitative data analysis J Nucl Med 50 2009 11S 20S
31. N.C. Gupta, A.R. Frank, and N.A. Dewan Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 184 1992 441 444
32. C.K. Kim, and N.C. Gupta Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction Nucl Med Commun 17 1996 890 894
33. H.M. Zhuang, A. Cortes-Blanco, and M. Pourdehnad Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun 22 2001 1123 1128
34. A. Ahmadian, M.R. Ay, and J.H. Bidgoli Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm Eur J Nucl Med Mol Imaging 35 2008 1812 1823
35. M. Abdoli, R.A. Dierckx, and H. Zaidi Metal artifact reduction strategies for improved attenuation correction in hybrid PET/CT imaging Med Phys 39 2012 3343 3360
36. R. Harnish, S. Prevrhal, and A. Alavi The effect of metal artefact reduction on CT-based attenuation correction for PET imaging in the vicinity of metallic hip implants: a phantom study Ann Nucl Med 28 2014 540 550
37. A. Salavati, S. Borofsky, and T.K. Boon-Kent Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions Mol Imaging Biol 2014 10.1007/s11307-014-0776-6 in press
38. R.A. Bundschuh, A. Martinez-Moller, and S.I. Ziegler Misalignment in PET/CT: relevance for SUV and therapy management Nuklearmedizin 47 2008 N14 N15
39. S.A. Nehmeh Respiratory motion correction strategies in thoracic PET-CT imaging PET Clin 8 2013 29 36
40. M. Soret, S.L. Bacharach, and I. Buvat Partial-volume effect in PET tumor imaging J Nucl Med 48 2007 932 945
41. S.M. Srinivas, T. Dhurairaj, and S. Basu A recovery coefficient method for partial volume correction of PET images Ann Nucl Med 23 2009 341 348
42. S. Surti, and J.S. Karp Imaging characteristics of a 3-dimensional GSO whole-body PET camera J Nucl Med 45 2004 1040 1049
43. O. Rousset, A. Rahmim, and A. Alavi Partial volume correction strategies in PET PET Clin 2 2007 235 249
44. M. Hickeson, M. Yun, and A. Matthies Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET Eur J Nucl Med Mol Imaging 29 2002 1639 1647
45. N. Avril, S. Bense, and S.I. Ziegler Breast imaging with fluorine-18-FDG PET: quantitative image analysis J Nucl Med 38 1997 1186 1191
46. M. Lubberink, V. Tolmachev, and C. Widstrom 110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET J Nucl Med 43 2002 1391 1397
47. R.L. Wahl, H. Jacene, and Y. Kasamon From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med 50 Suppl 1 2009 122S 150S
48. M. Vanderhoek, S.B. Perlman, and R. Jeraj Impact of different standardized uptake value measures on PET-based quantification of treatment response J Nucl Med 54 2013 1188 1194
49. M. Vanderhoek, S.B. Perlman, and R. Jeraj Impact of the definition of peak standardized uptake value on quantification of treatment response J Nucl Med 53 2012 4 11
50. A. Alavi, A.B. Newberg, and E. Souder Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators J Nucl Med 34 1993 1681 1687
51. S.M. Larson, Y. Erdi, and T. Akhurst Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis Clin Positron Imaging 2 1999 159 171
52. S. Basu, B. Saboury, and T. Werner Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders Mol Imaging Biol 13 2011 1051 1060
53. A. Berkowitz, S. Basu, and S. Srinivas Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET Nucl Med Commun 29 2008 521 526
54. B. Saboury, A. Salavati, and A. Brothers FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity Eur J Nucl Med Mol Imaging 41 2014 605 614
55. S. Abdulla, A. Salavati, and B. Saboury Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study Eur J Nucl Med Mol Imaging 41 2014 350 356
56. G.G. Bural, D.A. Torigian, and W. Chamroonrat Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept Nucl Med Biol 33 2006 1037 1043
57. M. Beheshti, B. Saboury, and N.N. Mehta Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography-a novel concept Hell J Nucl Med 14 2011 114 120
58. N.N. Mehta, D.A. Torigian, and J.M. Gelfand Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) J Vis Exp 63 2012 e3777
59. C. Van de Wiele, V. Kruse, and P. Smeets Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours Eur J Nucl Med Mol Imaging 40 2013 290 301
60. I. Naqa The role of quantitative PET in predicting cancer treatment outcomes Clin Transl Imaging 2 2014 305 320
61. 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis J Nucl Med 55 2014 414 422
62. G. Cheng, A. Alavi, and E. Lim Dynamic changes of FDG uptake and clearance in normal tissues Mol Imaging Biol 15 2013 345 352
63. 18F-FDG PET J Nucl Med 53 2012 693 700
64. I. El Naqa, P.W. Grigsby, and A. Apte Exploring feature-based approaches in PET images for predicting cancer treatment outcomes Pattern Recognit 42 2009 1162 1171
65. F. O'Sullivan, E. Wolsztynski, and J. O'Sullivan A statistical modeling approach to the analysis of spatial patterns of FDG-PET uptake in human sarcoma IEEE Trans Med Imaging 30 2011 2059 2071
66. H.J. Aerts, E.R. Velazquez, and R.T. Leijenaar Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach Nature Comm 5 2014 4006
67. G.R. Cook, M. Siddique, and B. Taylor Radiomics in PET: principles and applications Clin Transl Imaging 2 2014 269 276
68. V. Kumar, Y. Gu, and S. Basu Radiomics: the process and the challenges Magn Reson Imaging 30 2012 1234 1248
69. P. Lambin, E. Rios-Velazquez, and R. Leijenaar Radiomics: extracting more information from medical images using advanced feature analysis Eur J Cancer 48 2012 441 446
70. S.S. Gambhir Molecular imaging of cancer with positron emission tomography Nat Rev Cancer 2 2002 683 693
71. M.G. Vander Heiden, J.W. Locasale, and K.D. Swanson Evidence for an alternative glycolytic pathway in rapidly proliferating cells Science 329 2010 1492 1499
72. S. Mazurek Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells Int J Biochem Cell Biol 43 2011 969 980
73. 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer Cancer Res 72 2012 3725 3734
74. H. Zaidi, and I. El Naqa PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques Eur J Nucl Med Mol Imaging 37 2010 2165 2187
75. H. Zaidi, H. Vees, and M. Wissmeyer Molecular PET/CT imaging-guided radiation therapy treatment planning Acad Radiol 16 2009 1108 1133
76. A.C. Paulino, W.L. Thorstad, and T. Fox Role of fusion in radiotherapy treatment planning Semin Nucl Med 33 2003 238 243
77. A. Kirov, and L. Fanchon Pathology-validated PET image data sets and their role in PET segmentation Clin Transl Imaging 2 2014 253 267
78. D.A. Torigian, V. Dam, and X. Chen In vivo quantification of pulmonary inflammation in relation to emphysema severity via partial volume corrected (18)F-FDG-PET using computer-assisted analysis of diagnostic chest CT Hell J Nucl Med 16 2013 12 18
79. S. Basu, J. Kung, and M. Houseni Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions Q J Nucl Med Mol Imaging 53 2009 9 19
80. L.M. Hamberg, G.J. Hunter, and N.M. Alpert The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 35 1994 1308 1312
81. 18FDG uptake in soft tissue masses Eur J Nucl Med 26 1999 22 30
82. 18F-FDG PET imaging for differentiating malignant from inflammatory processes J Nucl Med 42 2001 1412 1417
83. E.K. Pauwels, M.J. Ribeiro, and J.H. Stoot FDG accumulation and tumor biology Nucl Med Biol 25 1998 317 322
84. E.L. Rosen, W.B. Eubank, and D.A. Mankoff FDG PET, PET/CT, and breast cancer imaging Radiographics 27 Suppl 1 2007 S215 S229
85. R. Kumar, V.A. Loving, and A. Chauhan Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET J Nucl Med 46 2005 1819 1824
86. 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes J Nucl Med 47 2006 1440 1446
87. 18F-FDG PET for the evaluation of pulmonary nodules J Nucl Med 43 2002 871 875
88. J.W. Lee, S.K. Kim, and S.M. Lee Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer Mol Imaging Biol 13 2011 565 572
89. R. Hustinx, R.J. Smith, and F. Benard Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck Eur J Nucl Med 26 1999 1345 1348
90. G. Cheng, D.A. Torigian, and H. Zhuang When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging 40 2013 779 787
91. S. Houshmand The role of dual and multiple time point imaging of FDG uptake in both normal and disease states Clin Transl Imaging 2 2014 281 293